Biosenta Inc. reported earnings results for the second quarter and six months ended March 31, 2022. For the second quarter, the company reported net loss was CAD 2.15 million compared to CAD 0.478921 million a year ago. Basic loss per share from continuing operations was CAD 0.11 compared to CAD 0.03 a year ago.
For the six months, sales was CAD 0.000292 million compared to CAD 0.150117 million a year ago. Revenue was CAD 0.000292 million compared to CAD 0.166724 million a year ago. Net loss was CAD 2.7 million compared to CAD 0.823025 million a year ago. Basic loss per share from continuing operations was CAD 0.14 compared to CAD 0.05 a year ago.